EP0980261A4 - Verfahren zur prävention und behandlung einer durch insulin hervorgerufenen metabolischen inbalance beim menschen und anderen tieren - Google Patents

Verfahren zur prävention und behandlung einer durch insulin hervorgerufenen metabolischen inbalance beim menschen und anderen tieren

Info

Publication number
EP0980261A4
EP0980261A4 EP98920967A EP98920967A EP0980261A4 EP 0980261 A4 EP0980261 A4 EP 0980261A4 EP 98920967 A EP98920967 A EP 98920967A EP 98920967 A EP98920967 A EP 98920967A EP 0980261 A4 EP0980261 A4 EP 0980261A4
Authority
EP
European Patent Office
Prior art keywords
insulate
humans
animals
treating
preventing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98920967A
Other languages
English (en)
French (fr)
Other versions
EP0980261A1 (de
Inventor
Marian L Kruzel
Gilbert A Castro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
University of Texas at Austin
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Publication of EP0980261A1 publication Critical patent/EP0980261A1/de
Publication of EP0980261A4 publication Critical patent/EP0980261A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP98920967A 1997-05-03 1998-04-30 Verfahren zur prävention und behandlung einer durch insulin hervorgerufenen metabolischen inbalance beim menschen und anderen tieren Withdrawn EP0980261A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4552197P 1997-05-03 1997-05-03
US45521P 1997-05-03
PCT/US1998/009053 WO1998050076A1 (en) 1997-05-03 1998-04-30 Methods for preventing and treating the insult-induced metabolic imbalance in humans and other animals

Publications (2)

Publication Number Publication Date
EP0980261A1 EP0980261A1 (de) 2000-02-23
EP0980261A4 true EP0980261A4 (de) 2003-04-23

Family

ID=21938377

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98920967A Withdrawn EP0980261A4 (de) 1997-05-03 1998-04-30 Verfahren zur prävention und behandlung einer durch insulin hervorgerufenen metabolischen inbalance beim menschen und anderen tieren

Country Status (5)

Country Link
EP (1) EP0980261A4 (de)
AU (1) AU7368198A (de)
CA (1) CA2288982A1 (de)
PL (1) PL336626A1 (de)
WO (1) WO1998050076A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030203839A1 (en) * 1999-10-29 2003-10-30 Kruzel Marian L. Immune enhancing composition containing lactoferrin
JP2006515879A (ja) * 2003-01-07 2006-06-08 エヌ．ブイ．・ヌートリシア 哺乳類による栄養利用を向上するための方法およびその中で使用するための組成物
ITMI20052351A1 (it) * 2005-12-09 2007-06-10 Microbo Srl Nuovo uso farmaceutico delle transferrine e composizioni farmaceutiche derivate

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4008033A1 (de) * 1990-03-14 1991-09-19 Nitsche Dietrich Verwendung von lactoferrin zur bekaempfung der toxischen wirkung des endotoxins
EP0559425A1 (de) * 1992-03-02 1993-09-08 Immuno Japan Inc. Formulierte Medizin zur Behandlung und/oder Verhütung von gelegentlichen infektiösen Erkrankungen mit Komplikation durch Infektion mit Lentivirus
EP0730868A1 (de) * 1995-02-17 1996-09-11 Tamotsu Satoh Formulierte Arzneimittel zur Behandlung von Mundentzündungen und verarbeitete Lebensmittel zur Behandlung und Verhütung von Mundentzündung
EP0753308A2 (de) * 1995-07-12 1997-01-15 Gambit International Limited Verwendung von Lactoferrin für Therapie von infektiösen akuten oder wiederholenden Krankheiten durch Streptococcus pyogenes oder anderen intrazellularen pathogenischen Grampositiven Bakterien
WO1998006425A1 (en) * 1996-08-12 1998-02-19 A+ Science Invest Ab Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin
WO1998033509A2 (en) * 1997-02-03 1998-08-06 Pharming Intellectual Property Bv Useful properties of human lactoferrin and variants thereof
WO1998044940A1 (en) * 1997-04-10 1998-10-15 Agennix, Inc. Use of lactoferin in the treatment of allergen induced disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977137B1 (en) * 1987-06-03 1994-06-28 Baylor College Medicine Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
US5792751A (en) * 1992-04-13 1998-08-11 Baylor College Of Medicine Tranformation of cells associated with fluid spaces

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4008033A1 (de) * 1990-03-14 1991-09-19 Nitsche Dietrich Verwendung von lactoferrin zur bekaempfung der toxischen wirkung des endotoxins
EP0559425A1 (de) * 1992-03-02 1993-09-08 Immuno Japan Inc. Formulierte Medizin zur Behandlung und/oder Verhütung von gelegentlichen infektiösen Erkrankungen mit Komplikation durch Infektion mit Lentivirus
EP0730868A1 (de) * 1995-02-17 1996-09-11 Tamotsu Satoh Formulierte Arzneimittel zur Behandlung von Mundentzündungen und verarbeitete Lebensmittel zur Behandlung und Verhütung von Mundentzündung
EP0753308A2 (de) * 1995-07-12 1997-01-15 Gambit International Limited Verwendung von Lactoferrin für Therapie von infektiösen akuten oder wiederholenden Krankheiten durch Streptococcus pyogenes oder anderen intrazellularen pathogenischen Grampositiven Bakterien
WO1998006425A1 (en) * 1996-08-12 1998-02-19 A+ Science Invest Ab Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin
WO1998033509A2 (en) * 1997-02-03 1998-08-06 Pharming Intellectual Property Bv Useful properties of human lactoferrin and variants thereof
WO1998044940A1 (en) * 1997-04-10 1998-10-15 Agennix, Inc. Use of lactoferin in the treatment of allergen induced disorders

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
FRITSCH G ET AL: "PLASMODIUM FALCIPARUM: INHIBITION IN VITRO WITH LACTOFERRIN, DESFERRIFERRITHIOCIN, AND DESFERRICROCIN", EXPERIMENTAL PARASITOLOGY, NEW YORK, NY, US, vol. 63, no. 1, February 1987 (1987-02-01), pages 1 - 9, XP000901232, ISSN: 0014-4894 *
GILLIN F D ET AL: "KILLING OF GIARDIA LAMBLIA TROPHOZOITES BY NORMAL HUMAN MILK", JOURNAL OF CELLULAR BIOCHEMISTRY, LISS, NEW YORK, NY, US, vol. 23, 1983, pages 47 - 56, XP000901160, ISSN: 0730-2312 *
MACHNICKI MICHAL ET AL: "Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo.", INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, vol. 74, no. 5, 1993, pages 433 - 439, XP009006113, ISSN: 0959-9673 *
See also references of WO9850076A1 *
ZAGULSKI T ET AL: "LACTOFERRIN CAN PROTECT MICE AGAINST A LETHAL DOSE OF ESCHERICHIA-COLI IN EXPERIMENTAL INFECTION IN-VITRO", BRITISH JOURNAL OF EXPERIMENTAL PATHOLOGY, vol. 70, no. 6, 1989, pages 697 - 704, XP009006349, ISSN: 0007-1021 *

Also Published As

Publication number Publication date
CA2288982A1 (en) 1998-11-12
PL336626A1 (en) 2000-07-03
WO1998050076A1 (en) 1998-11-12
AU7368198A (en) 1998-11-27
EP0980261A1 (de) 2000-02-23

Similar Documents

Publication Publication Date Title
EP0925046A4 (de) Topische zubereitungen und verfahren zur behandlung von hämorrhoiden
EP0979074A4 (de) Behandlung oder vorbeugung klimakteriumsymptomen und der osteoporose
ID25504A (id) Pencegahan dan pengobatan penyakit amiloidogenik
EP0964032A4 (de) Neue zusammensetzung und behandlungsmittel
ID29198A (id) Pemakaian uridin 5'-difosfat dan persamaannya untuk mengobati penyakit paru-paru
DE69823459D1 (de) Herzbehandlungssystem zur Feststellung und Behandlung von Herzversagen
DE69806801D1 (de) Galenische präparation zur prävention und behandlung von hepatokarzinomen
BR9711555A (pt) Composi-{es de naaladase e m-todos para tratar anomalia de glutamato e provocar atividade neuronal em animais
BR9711147A (pt) Tratamento de resfriado comum e rinite al-rgica
EP1239855A4 (de) Verfahren zur prevention und behandlung von arteriosklerose
BR9612283A (pt) Composição para o tratamento de manchas em peças de roupa e métodos de tratamento
DE69841550D1 (de) Behandlung von fibromyalgie und verwandten erkrankungen
NO996234L (no) Sprayformuleringer av antihyperalgesiske opiater og fremgangsmåte for behandling av topiske hyperalgesiske forhold og kløe med disse
UA10998C2 (uk) Спосіб поліфакторhої лікувальhої дії та ковдра для поліфакторhої лікувальhої дії
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE69925578D1 (de) Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten
NO20005659D0 (no) Anvendelse av "nanofood" i matvarer til mennesker og dyr
FR2772142B1 (fr) Procede de traitement antireflet et materiau presentant des proprietes antireflet
EP0980261A4 (de) Verfahren zur prävention und behandlung einer durch insulin hervorgerufenen metabolischen inbalance beim menschen und anderen tieren
NO990019L (no) Anvendelse av T-BAM (CD40L) ved behandling av sykdommer i glatt muskulatur
FR2731289B1 (fr) Procede et dispositif d'amelioration de la securite des etres vivants et plus particulierement des personnes
NO974486D0 (no) Lavdoserte "Ridogrel"-formuleringer samt anvendelse derav ved behandling av tarmbetennelse
ID19437A (id) Pengolahan dan komposisi untuk pengobatan anti-parasit di sekeliling tempat hewan-hewan
BR9708351A (pt) Métodos de tratamento de picadas e mordidas venenosas
AU5388299A (en) Antibodies for use in targeted and temporary treatment of humans and animals

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19991130

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20030310

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61P 33/00 B

Ipc: 7A 61P 31/00 B

Ipc: 7A 61P 29/00 B

Ipc: 7A 61K 38/40 A

17Q First examination report despatched

Effective date: 20030610

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20071031